Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03753113Phase 3Completed
Phase 3, randomised, double-blind trial in androgenetic alopecia (AGA) (2 arms). Primary endpoint: Change in Hair Diameter at 36 weeks. Started Nov 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03753113.